Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $6.1100 (5.34%) ($5.7000 - $6.2500) on Wed. Jun. 19, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 45 | Latest Price | $6.1100(5.34%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CEMI declines -6.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) ARKG(11%) IGOV(8%) VIXM(8%) XBI(8%) SHY(7%) | Factors Impacting CEMI price | CEMI will decline at least -1.47% in a week (0% probabilities). UNG(-11%) IFRA(-7%) XLP(-5%) VXX(-5%) XOP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | 0 () | Intraday Trend | 4.6% | | | |
|
1 - 5 Day Possible Target | $-6.72(-209.98%) | Resistance Level | $6.47 | 5 Day Moving Average | $5.92(3.21%) | 10 Day Moving Average | $6.14(-0.49%) | 20 Day Moving Average | $6.47(-5.56%) | To recent high | -22.2% | To recent low | 14.8% | Market Cap | $123m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |